Home LiteratureArticle Details
PMID: 18408925 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability.

Cancer immunology, immunotherapy : CII ·Vol. 57 ·No. 12 ·2008-12-00 ·Pages 1879-90

Schmidt MM, Thurber GM, Wittrup KD

Abstract

Theoretical analyses suggest that the cellular internalization and catabolism of bound antibodies contribute significantly to poor penetration into tumors. Here we quantitatively assess the internalization of antibodies and antibody fragments against the commonly targeted antigen carcinoembryonic antigen (CEA). Although CEA is often referred to as a non-internalizing or shed antigen, anti-CEA antibodies and antibody fragments are shown to be slowly endocytosed by LS174T cells with a half-time of 10-16 h, a time scale consistent with the metabolic turnover rate of CEA in the absence of antibody. Anti-CEA single chain variable fragments (scFvs) with significant differences in affinity, stability against protease digestion, and valency exhibit similar uptake rates of bound antibody. In contrast, one anti-CEA IgG exhibits unique binding and trafficking properties with twice as many molecules bound per cell at saturation and significantly faster cellular internalization after binding. The internalization rates measured herein can be used in simple computational models to predict the microdistribution of these antibodies in tumor spheroids.

MeSH Terms
Antibodies/chemistry,immunology,metabolism Antibody Affinity/immunology Carcinoembryonic Antigen/immunology Cell Line Humans Immunoglobulin Fragments/chemistry,immunology,metabolism
Chemicals
Antibodies Carcinoembryonic Antigen Immunoglobulin Fragments
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schmidt Michael M
Department of Biological Engineering, Massachusetts Institute of Technology, Building E19-551, 50 Ames Street, Cambridge, MA, 02139, USA.
Thurber Greg M
Wittrup K Dane
References (40)
40 references, click to expand
  1. Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding.
    J Nucl Med. 1995 May;36(5):867-76 PMID: 7738665
  2. Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy.
    Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):814-25 PMID: 15701872
  3. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.
    J Nucl Med. 1990 Jul;31(7):1191-8 PMID: 2362198
  4. Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors.
    Cancer. 2007 Jan 15;109(2):170-9 PMID: 17154393
  5. Delivery of molecular and cellular medicine to solid tumors.
    Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):149-68 PMID: 11259838
  6. Monoclonal antibody therapy of cancer.
    Nat Biotechnol. 2005 Sep;23(9):1147-57 PMID: 16151408
  7. Stabilization of antibody fragments in adverse environments.
    Biotechnol Appl Biochem. 1998 Aug;28(1):77-83 PMID: 9693092
  8. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer.
    Nucl Med Biol. 2005 Nov;32(8):851-8 PMID: 16253810
  9. Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure.
    Proc Natl Acad Sci U S A. 1987 May;84(9):2960-4 PMID: 3033671
  10. Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.
    Mol Biol Cell. 2004 Dec;15(12):5268-82 PMID: 15385631
  11. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
    Cancer Res. 2001 Jun 15;61(12):4750-5 PMID: 11406547
  12. Theoretic criteria for antibody penetration into solid tumors and micrometastases.
    J Nucl Med. 2007 Jun;48(6):995-9 PMID: 17504872
  13. Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody.
    Cytometry. 1996 Mar 1;23(3):228-40 PMID: 8974868
  14. Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response.
    Biotechnol Prog. 2000 Sep-Oct;16(5):905-16 PMID: 11027188
  15. Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 degrees C.
    Protein Eng Des Sel. 2004 Apr;17(4):293-304 PMID: 15115853
  16. Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs.
    Cancer Biother Radiopharm. 1999 Feb;14(1):37-47 PMID: 10850286
  17. The fate of antibodies bound to the surface of tumor cells in vitro.
    Cancer Res. 1992 Feb 15;52(4):835-42 PMID: 1737345
  18. Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
    J Nucl Med. 2006 Feb;47(2):247-55 PMID: 16455630
  19. Quantitative spatiotemporal analysis of antibody fragment diffusion and endocytic consumption in tumor spheroids.
    Cancer Res. 2008 May 1;68(9):3334-41 PMID: 18451160
  20. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Eur J Nucl Med. 2000 Jul;27(7):753-65 PMID: 10952487
  21. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1115-23 PMID: 16133391
  22. Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family.
    Proc Natl Acad Sci U S A. 1987 Feb;84(4):920-4 PMID: 3469650
  23. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.
    Cancer Res. 2003 Mar 15;63(6):1288-96 PMID: 12649189
  24. Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy.
    Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1915-20 PMID: 15684082
  25. Binding parameters of antibodies: pseudo-affinity and other misconceptions.
    Cancer Immunol Immunother. 2005 Jun;54(6):513-6 PMID: 15627210
  26. Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments.
    Nat Biotechnol. 1996 Oct;14(10):1239-45 PMID: 9631086
  27. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    J Nucl Med. 1997 Sep;38(9):1378-81 PMID: 9293791
  28. Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration.
    J Nucl Med. 2000 Jun;41(6):1016-20 PMID: 10855627
  29. Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.
    Nat Biotechnol. 2005 Feb;23(2):191-4 PMID: 15696150
  30. Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking.
    Science. 1994 Jun 24;264(5167):1948-51 PMID: 7516582
  31. Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy.
    J Mol Biol. 2002 Jun 28;320(1):107-27 PMID: 12079338
  32. Internalization of an intact doxorubicin immunoconjugate.
    Cancer Immunol Immunother. 1994 Feb;38(2):92-8 PMID: 8306371
  33. Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor.
    Cancer Res. 1995 Sep 1;55(17):3763-71 PMID: 7641191
  34. Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen.
    Mol Immunol. 1982 Dec;19(12):1641-8 PMID: 6186908
  35. Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization.
    J Biol Chem. 1990 Sep 15;265(26):15713-23 PMID: 1975591
  36. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    J Nucl Med. 2007 Feb;48(2):304-10 PMID: 17268029
  37. Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism.
    Microvasc Res. 1991 Jan;41(1):5-23 PMID: 2051954
  38. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues.
    Semin Cancer Biol. 1999 Apr;9(2):67-81 PMID: 10202129
  39. Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells.
    J Biol Chem. 1994 Nov 4;269(44):27595-602 PMID: 7961676
  40. A33 antigen displays persistent surface expression.
    Cancer Immunol Immunother. 2008 Jul;57(7):1017-27 PMID: 18236042
Article Info
Journal
Cancer immunology, immunotherapy : CII
Abbr.
Cancer Immunol Immunother
ISSN
0340-7004
Published
2008-12-00
Epub
2008-00-12
Pages
1879-90
Language
English
Region
Germany
NLM ID
8605732
PMCID
PMC2840397
Subset
IM
Grants
NCI NIH HHS · R01 CA101830-04 · United States
NIGMS NIH HHS · T32 GM008334 · United States
NCI NIH HHS · R01 CA096504-07 · United States
NCI NIH HHS · CA101830 · United States
NCI NIH HHS · R01 CA101830 · United States
NCI NIH HHS · R01 CA096504 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com